ZNF750 and esophageal squamous cell carcinoma: Our findings reveal an underlying mechanism by which loss-function of ZNF750 contributes to ESCC progression, provide a potential metastatic and prognostic biomarker and several therapeutic targets for ESCC patients harboring ZNF750 mutations and/or deletions.